NCT01874353 · BASELINE

Baseline characteristics

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy · Source last updated 2026-07-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
218
group Id
BG001
value
109
group Id
BG002
value
327
units
Participants

groups

description
Taken orally twice daily
id
BG000
title
Olaparib 300mg Tablets
description
Taken orally twice daily
id
BG001
title
Placebo Tablets
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
spread
9.2
value
57.0
group Id
BG001
spread
8.9
value
56.6
group Id
BG002
spread
9.09
value
56.9
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
spread
8.42
value
50.6
group Id
BG001
spread
9.29
value
47.4
group Id
BG002
spread
8.68
value
49.6
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Age, Continuous
unit Of Measure
Years
classes
categories
measurements
group Id
BG000
value
38
group Id
BG001
value
25
group Id
BG002
value
63
title
<50
measurements
group Id
BG000
value
118
group Id
BG001
value
52
group Id
BG002
value
170
title
>=50-<65
measurements
group Id
BG000
value
40
group Id
BG001
value
22
group Id
BG002
value
62
title
>=65
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
11
group Id
BG001
value
7
group Id
BG002
value
18
title
<50
measurements
group Id
BG000
value
10
group Id
BG001
value
2
group Id
BG002
value
12
title
>=50-<65
measurements
group Id
BG000
value
1
group Id
BG001
value
1
group Id
BG002
value
2
title
>=65
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
title
Female
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Male
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
Female
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Male
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
10
group Id
BG001
value
1
group Id
BG002
value
11
title
Hispanic or Latino
measurements
group Id
BG000
value
186
group Id
BG001
value
98
group Id
BG002
value
284
title
Not Hispanic or Latino
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Hispanic or Latino
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
Not Hispanic or Latino
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
173
group Id
BG001
value
91
group Id
BG002
value
264
title
WHITE
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
BLACK OR AFRICAN AMERICAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
AMERICAN INDIAN OR ALASKA NATIVE
measurements
group Id
BG000
value
22
group Id
BG001
value
7
group Id
BG002
value
29
title
ASIAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
measurements
group Id
BG000
value
0
group Id
BG001
value
1
group Id
BG002
value
1
title
OTHER
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
WHITE
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
BLACK OR AFRICAN AMERICAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
AMERICAN INDIAN OR ALASKA NATIVE
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
ASIAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
OTHER
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Race/Ethnicity, Customized
unit Of Measure
Participants

population Description

Global Cohort: 196 Olaparib, 99 Placebo China Cohort: 22 Olaparib, 10 Placebo

Complete source fields

denoms

counts
group Id
BG000
value
218
group Id
BG001
value
109
group Id
BG002
value
327
units
Participants

groups

description
Taken orally twice daily
id
BG000
title
Olaparib 300mg Tablets
description
Taken orally twice daily
id
BG001
title
Placebo Tablets
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
spread
9.2
value
57.0
group Id
BG001
spread
8.9
value
56.6
group Id
BG002
spread
9.09
value
56.9
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
spread
8.42
value
50.6
group Id
BG001
spread
9.29
value
47.4
group Id
BG002
spread
8.68
value
49.6
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Age, Continuous
unit Of Measure
Years
classes
categories
measurements
group Id
BG000
value
38
group Id
BG001
value
25
group Id
BG002
value
63
title
<50
measurements
group Id
BG000
value
118
group Id
BG001
value
52
group Id
BG002
value
170
title
>=50-<65
measurements
group Id
BG000
value
40
group Id
BG001
value
22
group Id
BG002
value
62
title
>=65
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
11
group Id
BG001
value
7
group Id
BG002
value
18
title
<50
measurements
group Id
BG000
value
10
group Id
BG001
value
2
group Id
BG002
value
12
title
>=50-<65
measurements
group Id
BG000
value
1
group Id
BG001
value
1
group Id
BG002
value
2
title
>=65
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
title
Female
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Male
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
Female
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Male
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
10
group Id
BG001
value
1
group Id
BG002
value
11
title
Hispanic or Latino
measurements
group Id
BG000
value
186
group Id
BG001
value
98
group Id
BG002
value
284
title
Not Hispanic or Latino
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Hispanic or Latino
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
Not Hispanic or Latino
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Unknown or Not Reported
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
173
group Id
BG001
value
91
group Id
BG002
value
264
title
WHITE
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
BLACK OR AFRICAN AMERICAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
AMERICAN INDIAN OR ALASKA NATIVE
measurements
group Id
BG000
value
22
group Id
BG001
value
7
group Id
BG002
value
29
title
ASIAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
measurements
group Id
BG000
value
0
group Id
BG001
value
1
group Id
BG002
value
1
title
OTHER
denoms
counts
group Id
BG000
value
196
group Id
BG001
value
99
group Id
BG002
value
295
units
Participants
title
Global Cohort
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
WHITE
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
BLACK OR AFRICAN AMERICAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
AMERICAN INDIAN OR ALASKA NATIVE
measurements
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
title
ASIAN
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
OTHER
denoms
counts
group Id
BG000
value
22
group Id
BG001
value
10
group Id
BG002
value
32
units
Participants
title
China Cohort
param Type
COUNT_OF_PARTICIPANTS
population Description
There are 196 Olaparib patients in the Global Cohort and 22 in the China Cohort (Total = 218). There are 99 Placebo patients in the Global Cohort and 10 in the China Cohort (Total = 109)
title
Race/Ethnicity, Customized
unit Of Measure
Participants

population Description

Global Cohort: 196 Olaparib, 99 Placebo China Cohort: 22 Olaparib, 10 Placebo

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice